A detailed history of Dearborn Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Dearborn Partners LLC holds 109,547 shares of JNJ stock, worth $17.5 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
109,547
Previous 111,215 1.5%
Holding current value
$17.5 Million
Previous $17.6 Million 8.99%
% of portfolio
0.7%
Previous 0.77%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$144.38 - $157.78 $240,825 - $263,177
-1,668 Reduced 1.5%
109,547 $16 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $100,116 - $104,967
-645 Reduced 0.58%
111,215 $17.6 Million
Q4 2023

Jan 26, 2024

SELL
$145.6 - $158.88 $63,918 - $69,748
-439 Reduced 0.39%
111,860 $17.5 Million
Q3 2023

Nov 01, 2023

SELL
$155.75 - $174.48 $41,585 - $46,586
-267 Reduced 0.24%
112,299 $17.5 Million
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $8.06 Million - $8.67 Million
-52,188 Reduced 31.68%
112,566 $18.6 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $497,105 - $593,235
3,291 Added 2.04%
164,754 $25.5 Million
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $74,172 - $83,242
-463 Reduced 0.29%
161,463 $28.5 Million
Q3 2022

Oct 25, 2022

BUY
$161.33 - $179.52 $6,130 - $6,821
38 Added 0.02%
161,926 $26.5 Million
Q2 2022

Jul 20, 2022

SELL
$168.19 - $186.01 $456,467 - $504,831
-2,714 Reduced 1.65%
161,888 $28.7 Million
Q1 2022

May 04, 2022

SELL
$158.14 - $179.59 $27.1 Million - $30.8 Million
-171,678 Reduced 51.05%
164,602 $29.2 Million
Q4 2021

Jan 28, 2022

SELL
$155.93 - $173.01 $536,243 - $594,981
-3,439 Reduced 1.01%
336,280 $57.5 Million
Q3 2021

Oct 27, 2021

BUY
$161.5 - $179.47 $102,875 - $114,322
637 Added 0.19%
339,719 $54.9 Million
Q2 2021

Jul 26, 2021

BUY
$159.48 - $171.07 $279,090 - $299,372
1,750 Added 0.52%
339,082 $55.9 Million
Q1 2021

Apr 29, 2021

BUY
$153.07 - $170.48 $208,940 - $232,705
1,365 Added 0.41%
337,332 $55.4 Million
Q4 2020

Jan 27, 2021

BUY
$137.11 - $157.38 $1.71 Million - $1.96 Million
12,463 Added 3.85%
335,967 $52.9 Million
Q3 2020

Oct 20, 2020

SELL
$140.38 - $153.83 $3,509 - $3,845
-25 Reduced 0.01%
323,504 $48.2 Million
Q2 2020

Jul 30, 2020

SELL
$128.81 - $155.51 $873,975 - $1.06 Million
-6,785 Reduced 2.05%
323,529 $45.5 Million
Q1 2020

May 11, 2020

BUY
$111.14 - $153.99 $93,913 - $130,121
845 Added 0.26%
330,314 $43.3 Million
Q4 2019

Jan 28, 2020

BUY
$127.5 - $146.44 $2.99 Million - $3.43 Million
23,448 Added 7.66%
329,469 $48.1 Million
Q3 2019

Oct 29, 2019

BUY
$126.95 - $142.14 $341,368 - $382,214
2,689 Added 0.89%
306,021 $39.6 Million
Q2 2019

Jul 29, 2019

BUY
$131.15 - $144.24 $923,427 - $1.02 Million
7,041 Added 2.38%
303,332 $42.2 Million
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $418,019 - $464,801
3,325 Added 1.13%
296,291 $41.4 Million
Q4 2018

Feb 04, 2019

BUY
$122.84 - $147.84 $1.08 Million - $1.3 Million
8,763 Added 3.08%
292,966 $37.8 Million
Q3 2018

Oct 24, 2018

BUY
$121.58 - $142.88 $745,650 - $876,283
6,133 Added 2.21%
284,203 $39.3 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $946,722 - $1.04 Million
-7,929 Reduced 2.77%
278,070 $33.7 Million
Q1 2018

May 01, 2018

SELL
$125.1 - $148.14 $1.21 Million - $1.44 Million
-9,702 Reduced 3.28%
285,999 $36.7 Million
Q4 2017

Feb 02, 2018

SELL
$131.22 - $143.62 $793,356 - $868,326
-6,046 Reduced 2.0%
295,701 $41.3 Million
Q3 2017

Nov 13, 2017

SELL
$129.47 - $135.38 $1.04 Million - $1.08 Million
-8,005 Reduced 2.58%
301,747 $39.2 Million
Q2 2017

Aug 09, 2017

BUY
N/A
309,752
309,752 $41 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.